FDA approves first next-gen sequencer

FDA approved the MiSeqDx genome sequencing system from Illumina Inc. (NASDAQ:ILMN) -- the first high-throughput, next-generation genomic sequencer to be approved by the agency.

Read the full 242 word article

How to gain access

Continue reading with a
two-week free trial.